UroGen Pharma Ltd. (URGN)
NASDAQ: URGN
· Real-Time Price · USD
19.74
-0.34 (-1.69%)
At close: Aug 15, 2025, 3:59 PM
19.50
-1.22%
After-hours: Aug 15, 2025, 06:59 PM EDT
UroGen Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 94.24M | 91.87M | 90.4M | 89.36M | 85.01M | 84.3M | 82.71M | 77.28M | 72.52M | 67.98M | 64.36M | 62.44M | 57.69M | 54.12M | 48.04M | 39.83M | 31.94M | 19.28M |
Cost of Revenue | 10.8M | 9.48M | 8.88M | 8.7M | 8.61M | 8.82M | 9.36M | 9.34M | 8.99M | 8.39M | 7.65M | 6.98M | 6.2M | 5.79M | 5.16M | 4.22M | 3.29M | 1.91M |
Gross Profit | 83.43M | 82.39M | 81.52M | 80.67M | 76.4M | 75.48M | 73.35M | 67.94M | 63.53M | 59.59M | 56.7M | 55.46M | 51.49M | 48.34M | 42.88M | 35.61M | 28.66M | 17.38M |
Operating Income | -123.56M | -107.96M | -96.78M | -83.73M | -79.69M | -69.23M | -65.54M | -71.21M | -75.8M | -79.13M | -79.04M | -78.67M | -84.03M | -88.14M | -92.29M | -99.63M | -105.31M | -114.29M |
Interest Income | 9.45M | 9.49M | 9.09M | 7M | 5.08M | 3.76M | 2.61M | 2.29M | 1.9M | 1.62M | 977K | 591K | 207K | 112K | 277K | 359K | 610K | 1.03M |
Pretax Income | -150.82M | -135.26M | -124.04M | -111.34M | -109.65M | -100.36M | -98.32M | -104.34M | -107.58M | -110.15M | -108.03M | -107.16M | -112.25M | -111.5M | -109.37M | -109.21M | -107.81M | -113.25M |
Net Income | -154.97M | -138.43M | -126.87M | -115.38M | -113.58M | -104.32M | -102.24M | -104.48M | -108.43M | -110.98M | -109.16M | -109.37M | -113.75M | -113.28M | -110.82M | -112.89M | -111.5M | -116.63M |
Selling & General & Admin | 141.97M | 128.82M | 121.15M | 110.85M | 103.66M | 96.1M | 93.27M | 90.36M | 87.67M | 86.01M | 82.84M | 82.62M | 85.17M | 86.65M | 87.53M | 88.28M | 88.72M | 90.44M |
Research & Development | 65.03M | 61.52M | 57.15M | 53.55M | 52.43M | 48.61M | 45.61M | 48.79M | 51.65M | 52.71M | 52.91M | 51.51M | 50.34M | 49.83M | 47.64M | 46.97M | 45.25M | 41.23M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -30K | -30K | -30K | 7K | 37K | 33K | 33K | -4K | -4K | n/a | n/a | n/a | n/a |
Operating Expenses | 207M | 190.34M | 178.3M | 164.4M | 156.09M | 144.71M | 138.89M | 139.15M | 139.32M | 138.72M | 135.74M | 134.13M | 135.52M | 136.47M | 135.18M | 135.25M | 133.97M | 131.67M |
Interest Expense | 24.04M | 18.73M | 12.52M | 12.21M | 13.31M | 13.61M | 14.71M | 14.35M | 13.23M | 11.71M | 8.44M | 12.63M | 9.94M | 7.7M | 7.42M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 47.59M | 47.59M | 47.59M | 47.59M | n/a | n/a | n/a |
Cost & Expenses | 217.8M | 199.83M | 187.18M | 173.1M | 164.7M | 153.53M | 148.25M | 148.48M | 148.32M | 147.11M | 143.4M | 141.11M | 141.72M | 142.26M | 140.33M | 139.47M | 137.26M | 133.58M |
Income Tax Expense | 3.36M | 2.39M | 2.83M | 4.04M | 3.94M | 3.95M | 3.92M | 135K | 853K | 831K | 1.14M | 2.2M | 1.49M | 1.77M | 1.45M | 3.69M | 3.69M | 3.37M |
Shares Outstanding (Basic) | 47.74M | 47.42M | 47.03M | 43.1M | 36.82M | 33.38M | 36.15M | 32.3M | 23.46M | 23.28M | 23.09M | 22.8M | 22.7M | 22.63M | 22.43M | 22.38M | 22.33M | 22.24M |
Shares Outstanding (Diluted) | 47.74M | 47.42M | 47.03M | 43.1M | 36.82M | 33.38M | 36.15M | 32.3M | 23.46M | 23.28M | 23.09M | 22.8M | 22.7M | 22.63M | 22.43M | 22.38M | 22.33M | 22.24M |
EPS (Basic) | -3.32 | -3.18 | -3.23 | -3.15 | -3.28 | -3.4 | -3.73 | -4.23 | -4.68 | -4.83 | -4.78 | -4.83 | -5.05 | -5.04 | -4.96 | -5.07 | -5.03 | -5.3 |
EPS (Diluted) | -3.32 | -3.18 | -3.23 | -3.15 | -3.28 | -3.4 | -3.73 | -4.23 | -4.68 | -4.83 | -4.78 | -4.83 | -5.05 | -5.04 | -4.96 | -5.07 | -5.03 | -5.3 |
EBITDA | -117.64M | -101.77M | -88.63M | -71.45M | -68.95M | -57.92M | -60.35M | -72.36M | -77.35M | -80.92M | -76.21M | -76.25M | -82.01M | -86.17M | -90.36M | -97.53M | -103.23M | -112.28M |
EBIT | -114.8M | -100.49M | -89.82M | -72.76M | -70.41M | -59.54M | -62.06M | -79.17M | -84.18M | -87.79M | -83.11M | -78.07M | -83.84M | -87.97M | -92.13M | -99.47M | -105.21M | -114.29M |
Depreciation & Amortization | 1.07M | 1.33M | 1.19M | 1.3M | 1.45M | 1.62M | 1.71M | 1.73M | 1.75M | 1.8M | 1.82M | 1.82M | 1.83M | 1.8M | 1.77M | 1.94M | 1.98M | 2.02M |